Programmed cell death 1 inhibits inflammatory helper T-cell deèelopment through controlling the innate immune response

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 40, 2013, Pages 16073-16078

  Rui, Yuxiang ^a   Honjo, Tasuku ^a   Chikuma, Shunsuke ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Autoimmunity; Inflammation

Indexed keywords

CD11B ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 23; INTERLEUKIN 4; INTERLEUKIN 6; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; PERTUSSIS TOXIN; PROGRAMMED DEATH 1 LIGAND 1; RAG2 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; B LYMPHOCYTE; BONE MARROW CELL; CD4+ T LYMPHOCYTE; CELL MATURATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; DISEASE SEVERITY; HEAT TREATMENT; IMMUNOREGULATION; INNATE IMMUNITY; LYMPHOCYTE DIFFERENTIATION; MACROPHAGE; MOLECULAR RECOGNITION; MOUSE; MYCOBACTERIUM; NONHUMAN; POLARIZATION; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH17 CELL; WILD TYPE;

CORYNEBACTERINEAE; MUS;

EID: 84885027255     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1315828110     Document Type: Article

References (45)

1. Okazaki T, Honjo T (2007) PD-1 and PD-1 ligands: From discovery to clinical application. Int Immunol 19(7):813-824.
2. Nishimura H, et al. (2001) Autoimmune dilated cardiomyopathy in PD-1 receptordeficient mice. Science 291(5502):319-322.
3. Nishimura H, Nose M, Hiai H, Minato N, Honjo T (1999) Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity 11(2):141-151.
4. Wang J, et al. (2010) PD-1 deficiency results in the development of fatal myocarditis in MRL mice. Int Immunol 22(6):443-452.
5. Prokunina L, et al. (2002) A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans. Nat Genet 32(4):666-669.
6. Nielsen C, Hansen D, Husby S, Jacobsen BB, Lillevang ST (2003) Association of a putative regulatory polymorphism in the PD-1 gene with susceptibility to type 1 diabetes. Tissue Antigens 62(6):492-497.
7. Prokunina L, et al. (2004) Association of the PD-1.3A allele of the PDCD1 gene in patients with rheumatoid arthritis negative for rheumatoid factor and the shared epitope. Arthritis Rheum 50(6):1770-1773.
8. Kroner A, et al. (2005) A PD-1 polymorphism is associated with disease progression in multiple sclerosis. Ann Neurol 58(1):50-57.
9. Liang SC, et al. (2003) Regulation of PD-1, PD-L1, and PD-L2 expression during normal and autoimmune responses. Eur J Immunol 33(10):2706-2716.
10. Salama AD, et al. (2003) Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis. J Exp Med 198(1):71-78.
11. Schreiner B, Bailey SL, Shin T, Chen L, Miller SD (2008) PD-1 ligands expressed on myeloid-derived APC in the CNS regulate T-cell responses in EAE. Eur J Immunol 38(10):2706-2717.
12. Kroner A, et al. (2009) Accelerated course of experimental autoimmune encephalomyelitis in PD-1-deficient central nervous system myelin mutants. Am J Pathol 174(6): 2290-2299.
13. Kroner A, et al. (2009) PD-1 regulates neural damage in oligodendroglia-induced inflammation. PLoS ONE 4(2):e4405.
14. Wang C, et al. (2009) Oestrogen modulates experimental autoimmune encephalomyelitis and interleukin-17 production via programmed death 1. Immunology 126(3): 329-335.
15. Zhu B, et al. (2006) Differential role of programmed death-ligand 1 [corrected] and programmed death-ligand 2 [corrected] in regulating the susceptibility and chronic progression of experimental autoimmune encephalomyelitis. J Immunol 176(6): 3480-3489.
16. Carter LL, et al. (2007) PD-1/PD-L1, but not PD-1/PD-L2, interactions regulate the severity of experimental autoimmune encephalomyelitis. J Neuroimmunol 182(1-2): 124-134.
17. Freeman GJ, et al. (2000) Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J Exp Med 192(7):1027-1034.
18. Latchman Y, et al. (2001) PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat Immunol 2(3):261-268.
19. Konkel JE, et al. (2010) PD-1 signalling in CD4(+) T cells restrains their clonal expansion to an immunogenic stimulus, but is not critically required for peptide-induced tolerance. Immunology 130(1):92-102.
20. Bettelli E, Korn T, Kuchroo VK (2007) Th17: The third member of the effector T cell trilogy. Curr Opin Immunol 19(6):652-657.
21. El-Behi M, et al. (2011) The encephalitogenicity of T(H)17 cells is dependent on IL-1-and IL-23-induced production of the cytokine GM-CSF. Nat Immunol 12(6):568-575.
22. Veldhoen M, Hocking RJ, Flavell RA, Stockinger B (2006) Signals mediated by transforming growth factor-beta initiate autoimmune encephalomyelitis, but chronic inflammation is needed to sustain disease. Nat Immunol 7(11):1151-1156.
23. Lázár-Molnár E, et al. (2010) Programmed death-1 (PD-1)-deficient mice are extraordinarily sensitive to tuberculosis. Proc Natl Acad Sci USA 107(30):13402-13407.
24. Barber DL, Mayer-Barber KD, Feng CG, Sharpe AH, Sher A (2011) CD4 T cells promote rather than control tuberculosis in the absence of PD-1-mediated inhibition. J Immunol 186(3):1598-1607.
25. Tousif S, et al. (2011) T cells from Programmed Death-1 deficient mice respond poorly to Mycobacterium tuberculosis infection. PLoS ONE 6(5):e19864.
26. Racke MK, Hu W, Lovett-Racke AE (2005) PTX cruiser: Driving autoimmunity via TLR4. Trends Immunol 26(6):289-291.
27. Chen X, et al. (2006) Pertussis toxin as an adjuvant suppresses the number and function of CD4+CD25+ T regulatory cells. Eur J Immunol 36(3):671-680.
28. Chen X, Howard OM, Oppenheim JJ (2007) Pertussis toxin by inducing IL-6 promotes the generation of IL-17-producing CD4 cells. J Immunol 178(10):6123-6129.
29. Wang C, Li Y, Proctor TM, Vandenbark AA, Offner H (2010) Down-modulation of programmed death 1 alters regulatory T cells and promotes experimental autoimmune encephalomyelitis. J Neurosci Res 88(1):7-15.
30. El-behi M, Rostami A, Ciric B (2010) Current views on the roles of Th1 and Th17 cells in experimental autoimmune encephalomyelitis. J Neuroimmune Pharmacol 5(2): 189-197.
31. Yao S, et al. (2009) PD-1 on dendritic cells impedes innate immunity against bacterial infection. Blood 113(23):5811-5818.
32. Huang X, et al. (2009) PD-1 expression by macrophages plays a pathologic role in altering microbial clearance and the innate inflammatory response to sepsis. Proc Natl Acad Sci USA 106(15):6303-6308.
33. Samoilova EB, Horton JL, Hilliard B, Liu TS, Chen Y (1998) IL-6-deficient mice are resistant to experimental autoimmune encephalomyelitis: Roles of IL-6 in the activation and differentiation of autoreactive T cells. J Immunol 161(12):6480-6486.
34. Serada S, et al. (2008) IL-6 blockade inhibits the induction of myelin antigen-specific Th17 cells and Th1 cells in experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA 105(26):9041-9046.
35. Jones GW, et al. (2010) Loss of CD4+ T cell IL-6R expression during inflammation underlines a role for IL-6 trans signaling in the local maintenance of Th17 cells. J Immunol 184(4):2130-2139.
36. Betz UA, Müller W (1998) Regulated expression of gp130 and IL-6 receptor alpha chain in T cell maturation and activation. Int Immunol 10(8):1175-1184.
37. Giacomini E, et al. (2001) Infection of human macrophages and dendritic cells with Mycobacterium tuberculosis induces a differential cytokine gene expression that modulates T cell response. J Immunol 166(12):7033-7041.
38. Hickman SP, Chan J, Salgame P (2002) Mycobacterium tuberculosis induces differential cytokine production from dendritic cells and macrophages with divergent effects on naive T cell polarization. J Immunol 168(9):4636-4642.
39. Méndez-Samperio P (2010) Role of interleukin-12 family cytokines in the cellular response to mycobacterial disease. Int J Infect Dis 14(5):e366-e371.
40. Chun JK, Jeon BY, Kang DW, Kim DS (2011) Bacille Calmette Guérin (BCG) can induce Kawasaki disease-like features in programmed death-1 (PD-1) gene knockout mice. Clin Exp Rheumatol 29(4):743-750.
41. Okazaki T, Maeda A, Nishimura H, Kurosaki T, Honjo T (2001) PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domaincontaining tyrosine phosphatase 2 to phosphotyrosine. Proc Natl Acad Sci USA 98(24): 13866-13871.
42. Cho HY, et al. (2008) Interferon-sensitive response element (ISRE) is mainly responsible for IFN-alpha-induced upregulation of programmed death-1 (PD-1) in macrophages. Biochim Biophys Acta 1779(12):811-819.
43. Terme M, et al. (2011) IL-18 induces PD-1-dependent immunosuppression in cancer. Cancer Res 71(16):5393-5399.
44. Alvarez IB, et al. (2010) Role played by the programmed death-1-programmed death ligand pathway during innate immunity against Mycobacterium tuberculosis. J Infect Dis 202(4):524-532.
45. Nishimura H, Minato N, Nakano T, Honjo T (1998) Immunological studies on PD-1 deficient mice: Implication of PD-1 as a negative regulator for B cell responses. Int Immunol 10(10):1563-1572.